In MM the use of humanized anti-IGF-1R antibody IMC-A12 (ImClone) has been shown to act in synergy with mTOR inhibitors, bortezomib and melphalan, in MM models in vitro and in vivo (68,76). This evidence concerns the gene IGF1R and Miyoshi myopathy.